Tracking Tumors with Calypso | Varian

Tracking Tumors with Calypso

Historically there has been one practical option for dealing with interfraction and intrafraction motion during stereotactic body radiotherapy (SBRT): increase the clinical target volume. Doing so, however, can also expose healthy organs and tissue to radiation. But, with FDA clearances for Calypso® Beacon® transponders for soft tissue and lung, clinicians today have a highly precise and effective way to monitor and adapt to tumor movement.

This article profiles three cancer programs that have used Calypso for SBRT:


Varian's Calypso system for tracking tumor motion